Good news|Shanghai Starry loversol lnjection approved for marketing

2023-10-31

On 27th October, according to NMPA’s public information, Shanghai Starry declared the Ioversol injection (National Medical Standards H20234353) was approved and obtained the drug registration certificate (Deemed to pass consistency evaluation).

The approval of Ioversol injection is as an important step for Starry to pursue the strategy of whole industry chain for contrast agent. Up to now, Starry has become one of the enterprises with the largest number of approved iodine contrast agents among domestic generic drug enterprises, and the approved products include iohexol injection, iopamidol injection, iodixanol injection, iomeprol injection and ioversol injection. In the future,Starry is firmly committed to this strategy and persisting in buildingup its core competitivenessof API and FDF Integration. Aimed to provide more medicines of high quality to domestic customers, Starry is working hard to further deepening the technological R&D and product innovation in the field of medical imaging.

loversol lnjection

Ioversol injection was firstly developed by Mallinckrodt Company in the United States, which belongs to a kind of non-ionic, low-permeability, water-soluble, monomer X-ray contrast agent. Ioversol injection was approved by the FDA in 1988 and listed on the market in the U.S.A. under the trade name of "Optiray". It entered the Chinese market in 1999, entered the category B of medical insurance in 2000 and category A of medical insurance in 2009.

Last page

Good news | Jiangxi Starry Gadobenate dimeglumine API approved for marketing

Gather Together Again, Look Forward to A New Future| Starry at CPHI Barcelona

Last page

Good news | Jiangxi Starry Gadobenate dimeglumine API approved for marketing

Gather Together Again, Look Forward to A New Future| Starry at CPHI Barcelona

Related news

2024-02-29

Bureau of Statistics Shanghai Jinshan District Visited Shanghai Starry

2024-02-22

Good news | Jiangxi Starry Gadobenate dimeglumine API approved for marketing

2023-10-31